RFA
TELA icon

Rollins Financial Advisors’s TELA Bio TELA Stock Holding History

Rollins Financial Advisors’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-18,656
Closed -$36.2K – 152
2025
Q2 		$36.2K Hold
18,656
– – 0.01% 140
2025
Q1 		$22.8K Buy
+18,656
New +$45.9K ﹤0.01% 130

Other funds holding TELA

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Rollins Financial Advisors's TELA Position: Q3 2025 in Review

Rollins Financial Advisors sold out of TELA Bio (TELA) in Q3 2025, closing a stake of 18,656 shares — an estimated $36.2K sold.

Rollins Financial Advisors first reported a position in TELA in Q1 2025 and held it in 2 quarters. The position peaked at $36.2K in Q2 2025. 40 funds tracked by Wall St. Rank hold TELA as of Q3 2025.

  • Rollins Financial Advisors reported no remaining TELA Bio position as of Q3 2025 after selling out during the quarter.
  • Rollins Financial Advisors sold 18,656 TELA Bio shares in Q3 2025, an estimated $36.2K.
  • Rollins Financial Advisors first reported a position in TELA Bio in Q1 2025 and held it in 2 quarters.
  • Rollins Financial Advisors's TELA Bio position peaked at $36.2K in Q2 2025.
  • 40 funds tracked by Wall St. Rank held TELA Bio as of Q3 2025.

Based on Rollins Financial Advisors's 13F filing for Q3 2025, filed 10 Nov 2025.